FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115161719> ?p ?o ?g. }

• W2115161719 endingPage "1512" @default.
• W2115161719 startingPage "1507" @default.
• W2115161719 abstract "The major significance of the capsular polysaccharide of C. neoformans is its role in potentiating opportunistic infections by the yeast. It has the ability to exert a broad spectrum of influences on the immune response, from activation of phagocytic cells and complement components of the alternative pathway, to the induction of specific antibody, T-suppressor cells, DTH responses, and cytokines (51). These biological properties along with the serotype specificities are all determined by the physical properties and chemical structures of the polysaccharide antigens that compose the capsule. There is evidence not only for an association of lethal infections with serotype A in patients with advanced AIDS (34, 56), but also for a role for the capsule in directly influencing the infection of CD4+ cells by HIV (57). Together, these phenomena raise intriguing questions about the possible connection between the chemistry of these capsular antigens and cryptococcal infections in AIDS patients. One speculation is that AIDS creates the optimal physiological conditions for the establishment and spread of cryptococcosis. It has been observed that during the progression of AIDS there is a shift towards a T-2 response (14). This could lead to conditions that would inhibit the cellular immune responses that block dissemination of cryptococcal infections. Thus, an important consideration in the application of vaccine or immune modulation therapies in the treatment of cryptococcosis in AIDS victims would be the design of vaccines that could boost the T-1 immune response. It has been shown that the form and dose of an antigenic challenge can influence the induction of a T-1 or T-2 immune response (61). Recently, Murphy has reported that gamma interferon and interleukin 2 are up-regulated in the spleens of mice that produce anticryptococcal TDH and TAMP cells in response to immunogenic doses of cryptococcal culture filtrate antigen given with Freund's complete adjuvant (49). Perhaps purified cryptococcal antigens (e.g., MP) conjugated to an appropriate carrier or adjuvant could be used in therapeutic strategies to limit cryptococcosis in immunocompromised individuals. Future investigations of virulence and pathogenicity in the context of defined polysaccharide antigens from encapsulated strains of C. neoformans will contribute to a better understanding of the regulation of cryptococcal infection and immunity at the cellular and molecular levels.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2115161719 created "2016-06-24" @default.
• W2115161719 creator A5017246100 @default.
• W2115161719 creator A5070711436 @default.
• W2115161719 date "1994-05-01" @default.
• W2115161719 modified "2023-10-12" @default.
• W2115161719 title "Polysaccharide antigens of the capsule of Cryptococcus neoformans" @default.
• W2115161719 cites W128822812 @default.
• W2115161719 cites W14003297 @default.
• W2115161719 cites W1497378726 @default.
• W2115161719 cites W1535869126 @default.
• W2115161719 cites W1567581543 @default.
• W2115161719 cites W1577968905 @default.
• W2115161719 cites W1595352374 @default.
• W2115161719 cites W1603466950 @default.
• W2115161719 cites W1605992623 @default.
• W2115161719 cites W1606519489 @default.
• W2115161719 cites W1712993486 @default.
• W2115161719 cites W1756749354 @default.
• W2115161719 cites W1780395944 @default.
• W2115161719 cites W1824251371 @default.
• W2115161719 cites W1845159538 @default.
• W2115161719 cites W1860530067 @default.
• W2115161719 cites W1866020018 @default.
• W2115161719 cites W1892422202 @default.
• W2115161719 cites W1893836388 @default.
• W2115161719 cites W1901701822 @default.
• W2115161719 cites W1909484110 @default.
• W2115161719 cites W1912169188 @default.
• W2115161719 cites W1918132033 @default.
• W2115161719 cites W1921307544 @default.
• W2115161719 cites W1933113401 @default.
• W2115161719 cites W1944932482 @default.
• W2115161719 cites W1949975351 @default.
• W2115161719 cites W1952385550 @default.
• W2115161719 cites W1958951903 @default.
• W2115161719 cites W1959967360 @default.
• W2115161719 cites W1960148657 @default.
• W2115161719 cites W1963286479 @default.
• W2115161719 cites W1963958510 @default.
• W2115161719 cites W1989491358 @default.
• W2115161719 cites W1990871997 @default.
• W2115161719 cites W1995304575 @default.
• W2115161719 cites W1998820252 @default.
• W2115161719 cites W2016190837 @default.
• W2115161719 cites W2017398931 @default.
• W2115161719 cites W2028437363 @default.
• W2115161719 cites W2031724082 @default.
• W2115161719 cites W2039823714 @default.
• W2115161719 cites W2047947597 @default.
• W2115161719 cites W2054403165 @default.
• W2115161719 cites W2063513729 @default.
• W2115161719 cites W2068554651 @default.
• W2115161719 cites W2068580653 @default.
• W2115161719 cites W2076223532 @default.
• W2115161719 cites W2076560869 @default.
• W2115161719 cites W2086989632 @default.
• W2115161719 cites W2097794822 @default.
• W2115161719 cites W2103390933 @default.
• W2115161719 cites W2104912668 @default.
• W2115161719 cites W2105191684 @default.
• W2115161719 cites W2105236799 @default.
• W2115161719 cites W2111189608 @default.
• W2115161719 cites W2111679190 @default.
• W2115161719 cites W2115437520 @default.
• W2115161719 cites W2131747421 @default.
• W2115161719 cites W2132743118 @default.
• W2115161719 cites W2134332505 @default.
• W2115161719 cites W2135468473 @default.
• W2115161719 cites W2153174613 @default.
• W2115161719 cites W2155522308 @default.
• W2115161719 cites W2316468762 @default.
• W2115161719 cites W2320035528 @default.
• W2115161719 cites W2331988045 @default.
• W2115161719 cites W2334889527 @default.
• W2115161719 cites W2336331516 @default.
• W2115161719 cites W2399369252 @default.
• W2115161719 cites W2416827631 @default.
• W2115161719 cites W2426493726 @default.
• W2115161719 cites W36155770 @default.
• W2115161719 cites W2062254434 @default.
• W2115161719 doi "https://doi.org/10.1128/iai.62.5.1507-1512.1994" @default.
• W2115161719 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/186341" @default.
• W2115161719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8168912" @default.
• W2115161719 hasPublicationYear "1994" @default.
• W2115161719 type Work @default.
• W2115161719 sameAs 2115161719 @default.
• W2115161719 citedByCount "291" @default.
• W2115161719 countsByYear W21151617192012 @default.
• W2115161719 countsByYear W21151617192013 @default.
• W2115161719 countsByYear W21151617192014 @default.
• W2115161719 countsByYear W21151617192015 @default.
• W2115161719 countsByYear W21151617192016 @default.
• W2115161719 countsByYear W21151617192017 @default.
• W2115161719 countsByYear W21151617192018 @default.
• W2115161719 countsByYear W21151617192019 @default.
• W2115161719 countsByYear W21151617192020 @default.
• W2115161719 countsByYear W21151617192021 @default.

• next